Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilberto Lopes

Showing results (61-70 of 177) with videos related to

Pageof 18
Sort By:
Clinical Colorectal Cancer|October 20, 2007
Oxaliplatin and fixed-rate infusional gemcitabine in the second-line treatment of patients with metastatic colon cancer: final results of a Phase II trial prematurely closed as a result of poor accrualGilberto Lopes, Jose Quesada, Eugene Ahn, et al.
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|February 2, 2017
Oxaliplatin-related neuropathy in Indian patients - no difference between generic and original moleculesBhawna Sirohi, Vikas Ostwal, Shaheenah Dawood, et al.
Critical Reviews in Oncogenesis|April 29, 2024
Disparities in Electronic Cigarette Use: A Narrative ReviewKyle Edwards, Aysswarya Manoharan, Taghrid Asfar, et al.
Nature Cancer|April 30, 2020
Crowdsourcing a crisis response for COVID-19 in oncologyAakash Desai, Jeremy Warner, Nicole Kuderer, et al.
Clinical Breast Cancer|September 1, 2006
Primary ectopic breast cancer presenting as a vulvar massGilberto Lopes, Teresa DeCesare, Giselle Ghurani, et al.
Nature Cancer|February 5, 2022
Crowdsourcing a crisis response for COVID-19 in oncologyAakash Desai, Jeremy Warner, Nicole Kuderer, et al.
Breast Cancer Research and Treatment|September 26, 2012
Impact of biomarkers on clinical trial risk in breast cancerJayson L Parker, Nadia Lushina, Prabjot S Bal, et al.
The Oncologist|August 22, 2022
The Effect of Biomarker Use on the Speed and Duration of Clinical Trials for Cancer DrugsLuqmaan Mohamed, Siddhi Manjrekar, Derek P Ng, et al.
Revista Da Associacao Medica Brasileira (1992)|February 23, 2017
A "miracle" cancer drug in the era of social media: A survey of Brazilian oncologists' opinions and experience with phosphoethanolamineJuliana Florinda M Rêgo, Gilberto Lopes, Rachel P Riechelmann, et al.
Clinical Colorectal Cancer|October 20, 2007
Phase II trial of 5-fluorouracil/leucovorin/gemcitabine/cisplatin as second-line treatment in patients with metastatic or recurrent colorectal carcinoma: a cancer therapeutics research group studyAlex Y Chang, Gilberto Lopes, Koo Wen Hsin, et al.
Pageof 18

Showing results (61-70 of 177) with videos related to

Sort By:
Pageof 18
Clinical Colorectal Cancer|October 20, 2007
Oxaliplatin and fixed-rate infusional gemcitabine in the second-line treatment of patients with metastatic colon cancer: final results of a Phase II trial prematurely closed as a result of poor accrualGilberto Lopes, Jose Quesada, Eugene Ahn, et al.
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|February 2, 2017
Oxaliplatin-related neuropathy in Indian patients - no difference between generic and original moleculesBhawna Sirohi, Vikas Ostwal, Shaheenah Dawood, et al.
Critical Reviews in Oncogenesis|April 29, 2024
Disparities in Electronic Cigarette Use: A Narrative ReviewKyle Edwards, Aysswarya Manoharan, Taghrid Asfar, et al.
Nature Cancer|April 30, 2020
Crowdsourcing a crisis response for COVID-19 in oncologyAakash Desai, Jeremy Warner, Nicole Kuderer, et al.
Clinical Breast Cancer|September 1, 2006
Primary ectopic breast cancer presenting as a vulvar massGilberto Lopes, Teresa DeCesare, Giselle Ghurani, et al.
Nature Cancer|February 5, 2022
Crowdsourcing a crisis response for COVID-19 in oncologyAakash Desai, Jeremy Warner, Nicole Kuderer, et al.
Breast Cancer Research and Treatment|September 26, 2012
Impact of biomarkers on clinical trial risk in breast cancerJayson L Parker, Nadia Lushina, Prabjot S Bal, et al.
The Oncologist|August 22, 2022
The Effect of Biomarker Use on the Speed and Duration of Clinical Trials for Cancer DrugsLuqmaan Mohamed, Siddhi Manjrekar, Derek P Ng, et al.
Revista Da Associacao Medica Brasileira (1992)|February 23, 2017
A "miracle" cancer drug in the era of social media: A survey of Brazilian oncologists' opinions and experience with phosphoethanolamineJuliana Florinda M Rêgo, Gilberto Lopes, Rachel P Riechelmann, et al.
Clinical Colorectal Cancer|October 20, 2007
Phase II trial of 5-fluorouracil/leucovorin/gemcitabine/cisplatin as second-line treatment in patients with metastatic or recurrent colorectal carcinoma: a cancer therapeutics research group studyAlex Y Chang, Gilberto Lopes, Koo Wen Hsin, et al.
Pageof 18